Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How Important Are Ozempic and Wegovy to Novo Nordisk's Business?

TheMotleyFool

0 0

How Important Are Ozempic and Wegovy to Novo Nordisk's Business?: https://g.foolcdn.com/editorial/images/763866/novo-nordisk-quarterly-results-shown-in-a-chart.png

At the start of 2020, Novo Nordisk (NYSE: NVO) was worth around $150 billion. Today, its market capitalization is north of $500 billion as it is now one of the most valuable healthcare companies in the world.

A big part of that reason is the rising popularity of two drugs: Ozempic and Wegovy. Both have been associated with helping patients shed significant amounts of weight. Thanks to social media, demand for the treatments has been through the roof, and that has sent the stock to new heights.

But just how dependent is Novo Nordisk on these two drugs, and does that pose a risk to investors?

Source Fool.com

Like: 0

NVO

Share